⏳ Fetching live dividend data...
Home › Calculator › LYPHF Dividend Calculator 2026
Luye Pharma Group Ltd. · OTC
Price: $0.20 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LYPHF → $1.23M in 10 years · $2,518.79/month
Luye Pharma Group Ltd., serving as an investment holding company, engages in the global research, development, production, commercialization, and distribution of a diverse portfolio of pharmaceutical products. Their oncology treatments include Lipusu, indicated for ovarian and breast cancer; CMNa, a chemical sensitizer used in cancer radiotherapy; Tiandida, targeting ovarian or non-small cell lung cancer; and Boyounuo, an injection addressing various cancers and solid tumors. The company also provides Tiandixin, an adjuvant therapy for malignant tumors, hydrothorax, ascites, and respiratory infections; Yitaida, for acute promyelocytic leukemia and liver cancer; and Lutingnuo, a glutathione injection counteracting toxicity and injuries from ionizing radiation. For metabolic and cardiovascular health, their offerings comprise Xuezhikang, a lipid-regulating drug for hypercholesterolaemia; Beixi, an acarbose capsule for Type 2 diabetes; and Beitangning, a pioglitazone hydrochloride capsule designed to manage blood glucose. In neurology and psychiatry, Luye Pharma provides Maitongna for cerebral edema resulting from trauma or surgery, and for venous reflux disorders. Their pipeline features the Rivastigmine Transdermal Patch for Alzheimer's disease; Fentanyl Transdermal Patch for cancer-related pain; and Buprenorphine Transdermal Patch for chronic pain. They also market Seroquel and Seroquel XR for schizophrenia and manic episodes of bipolar affective disorders, alongside Rykindo, an injectable treatment for schizophrenia. Other specialized products include Nuosen for acute upper digestive tract hemorrhage; Sailimai for the management of diarrhea; the Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for localized swelling; Oukai, for soft tissue swelling and venous edema; and Fengshiye, intended for patients experiencing bone, joint, and limb pain. Beyond traditional pharmaceuticals, the company also extends its operations to include the manufacturing and commercialization of biopharmaceutical products. Luye Pharma Group Ltd. was established in 1994 and is headquartered in Yantai, People's Republic of China.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LYPHF position with:
Real after-tax yield depends on where you live and how you hold LYPHF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 979.91% | 977.11% | $97,991 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 832.92% | 830.12% | $83,292 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 783.93% | 781.13% | $78,393 / yr |
| 🇬🇧 UK ISA | 0% | 979.91% | 977.11% | $97,991 / yr |
| 🇬🇧 UK Taxable | 8.75% | 894.17% | 891.37% | $89,417 / yr |
| 🇨🇦 TFSA | 0% | 979.91% | 977.11% | $97,991 / yr |
| 🇨🇦 CA Taxable | 25% | 734.93% | 732.13% | $73,493 / yr |
| 🇦🇺 Super (pension) | 15% | 832.92% | 830.12% | $83,292 / yr |
| 🇦🇺 AU Taxable | 30% | 685.94% | 683.14% | $68,594 / yr |
| 🇩🇪 DE Taxable | 26.375% | 721.46% | 718.66% | $72,146 / yr |
| 🇫🇷 FR Taxable | 30% | 685.94% | 683.14% | $68,594 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
LYPHF pays quarterly — 4 times per year. Next ex-div: TBD.
How LYPHF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LYPHF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LYPHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Luye Pharma Group Ltd. (LYPHF) is currently trading at $0.20, trading near its 52-week low. The current dividend yield is 979.91% based on an annual payout of $2.00 per share.
Luye Pharma Group Ltd. (LYPHF) is a healthcare stock currently trading at $0.20 with a dividend yield of 979.91%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, LYPHF has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →